HEIDELBERG achieves significant improvement in profitability after nine months of FY 2025/26 – strategic realignment ...
Akkodis, a Europe based global digital engineering consulting leader – part of The Adecco Group - together with POLITICO, ...
14h
Grünenthal licenses exclusive Canadian rights to testosterone replacement therapy Nebido to Apotex
Under the agreement, Searchlight Pharma, Apotex's branded medicine division, will pursue marketing authorisation and will market and distribute the product in Canada upon regulatory approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results